SEC 13F Intelligence

Sg Americas Securities, LLC / EW

Sg Americas Securities, LLC’s Edwards Lifesciences Corp Position

Does Sg Americas Securities, LLC own Edwards Lifesciences Corp (EW)? Yes980.6K shares worth $79M (+0.08% of its 13F portfolio) as of Q1 2026, up from 593.5K shares the prior filed quarter.

Position Value
$79M
Q1 2026
Shares
980.6K
% of Portfolio
+0.08%
Quarters Held
30
currently held

Position History EW

Reported value by quarter
Q4 ’18: $4MQ4 ’18Q1 ’19: $898,000Q2 ’19: $13MQ3 ’19: $140,000Q4 ’19: $542,000Q4 ’19Q1 ’20: $6MQ2 ’20: $3MQ3 ’20: $1MQ4 ’20: $7MQ4 ’20Q1 ’21: $643,000Q2 ’21: $5MQ3 ’21: $2MQ4 ’21: $5MQ4 ’21Q1 ’22: $875,000Q2 ’22: $2MQ3 ’22: $4MQ4 ’22: $642,000Q4 ’22Q1 ’23: $2MQ2 ’23: $3MQ3 ’23: $3MQ4 ’23: $2MQ4 ’23Q1 ’24: $9MQ2 ’24: $8MQ3 ’24: $2MQ4 ’24: $75MQ4 ’24Q1 ’25: $55MQ2 ’25: $2MQ3 ’25: $45MQ4 ’25: $51MQ4 ’25Q1 ’26: $79Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026980.6K$79M+0.08%
Q4 2025593.5K$51M+0.06%
Q3 2025578.1K$45M+0.15%
Q2 202520.2K$2M+0.01%
Q1 2025759.4K$55M+0.18%
Q4 20241.01M$75M+0.31%
Q3 202425.5K$2M+0.01%
Q2 202484.3K$8M+0.05%
Q1 202497.6K$9M+0.04%
Q4 202329.0K$2M+0.02%
Q3 202337.5K$3M+0.03%
Q2 202335.7K$3M+0.03%
Q1 202324.5K$2M+0.02%
Q4 20228.6K$642,000+0.01%
Q3 202249.2K$4M+0.05%
Q2 202217.3K$2M+0.02%
Q1 20227.4K$875,000+0.01%
Q4 202138.6K$5M+0.03%
Q3 202117.2K$2M+0.01%
Q2 202147.0K$5M+0.02%
Q1 20217.7K$643,0000.00%
Q4 202073.5K$7M+0.04%
Q3 202016.2K$1M+0.01%
Q2 202041.1K$3M+0.02%
Q1 202033.2K$6M+0.06%
Q4 20192.3K$542,0000.00%
Q3 2019637$140,0000.00%
Q2 201970.0K$13M+0.09%
Q1 20194.7K$898,000+0.01%
Q4 201827.4K$4M+0.04%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sg Americas Securities, LLC’s full portfolio or all institutional holders of EW.